Literature DB >> 27980489

Intestinal Microbiome, Akkermansia muciniphila, and Medical Nutrition Therapy.

Jeffrey Bland1.   

Abstract

The gastrointestinal microbiome has become a topic of great interest in medicine in recent years. Genomic sequencing can now be done at a fraction of the cost of a few years ago, and this has allowed for the development and compilation of an extensive amount of data related to the species diversity of the human gastrointestinal microbiome.1 Studies have demonstrated that the intestinal microbiome is sensitive to the composition of the diet.2 It is also recognized that the composition of the microbiome can be altered rapidly in response to dietary changes, stress, chemical exposure, and exercise.3 Both the expanded understanding of the composition of the human microbiome and the ability to measure it through genomic analysis of the stool have resulted in clinicians frequently wanting to know what actionable conclusions can be taken away from an analysis of the gastrointestinal microbiome.

Entities:  

Year:  2016        PMID: 27980489      PMCID: PMC5145007     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  28 in total

1.  Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.

Authors:  Maria Carlota Dao; Amandine Everard; Judith Aron-Wisnewsky; Nataliya Sokolovska; Edi Prifti; Eric O Verger; Brandon D Kayser; Florence Levenez; Julien Chilloux; Lesley Hoyles; Marc-Emmanuel Dumas; Salwa W Rizkalla; Joel Doré; Patrice D Cani; Karine Clément
Journal:  Gut       Date:  2015-06-22       Impact factor: 23.059

2.  Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system.

Authors:  Sandra Macfarlane; Emma J Woodmansey; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

Review 3.  Functional effects of food components and the gastrointestinal system: chicory fructooligosaccharides.

Authors:  M B Roberfroid
Journal:  Nutr Rev       Date:  1996-11       Impact factor: 7.110

4.  Diets that differ in their FODMAP content alter the colonic luminal microenvironment.

Authors:  Emma P Halmos; Claus T Christophersen; Anthony R Bird; Susan J Shepherd; Peter R Gibson; Jane G Muir
Journal:  Gut       Date:  2014-07-12       Impact factor: 23.059

5.  Intestinal mucus barrier in normal and inflamed colon.

Authors:  Enrico Stefano Corazziari
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-04       Impact factor: 2.839

6.  Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer.

Authors:  Justus Reunanen; Veera Kainulainen; Laura Huuskonen; Noora Ottman; Clara Belzer; Heikki Huhtinen; Willem M de Vos; Reetta Satokari
Journal:  Appl Environ Microbiol       Date:  2015-03-20       Impact factor: 4.792

7.  Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets.

Authors:  Emma P Halmos; Claus T Christophersen; Anthony R Bird; Susan J Shepherd; Jane G Muir; Peter R Gibson
Journal:  Clin Transl Gastroenterol       Date:  2016-04-14       Impact factor: 4.488

8.  Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes.

Authors:  Moran Yassour; Mi Young Lim; Hyun Sun Yun; Timothy L Tickle; Joohon Sung; Yun-Mi Song; Kayoung Lee; Eric A Franzosa; Xochitl C Morgan; Dirk Gevers; Eric S Lander; Ramnik J Xavier; Bruce W Birren; GwangPyo Ko; Curtis Huttenhower
Journal:  Genome Med       Date:  2016-02-17       Impact factor: 11.117

Review 9.  Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.

Authors:  Andrea Michielan; Renata D'Incà
Journal:  Mediators Inflamm       Date:  2015-10-25       Impact factor: 4.711

10.  Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.

Authors:  Thibaut Duparc; Hubert Plovier; Vannina G Marrachelli; Matthias Van Hul; Ahmed Essaghir; Marcus Ståhlman; Sébastien Matamoros; Lucie Geurts; Mercedes M Pardo-Tendero; Céline Druart; Nathalie M Delzenne; Jean-Baptiste Demoulin; Schalk W van der Merwe; Jos van Pelt; Fredrik Bäckhed; Daniel Monleon; Amandine Everard; Patrice D Cani
Journal:  Gut       Date:  2016-05-05       Impact factor: 23.059

View more
  8 in total

1.  Interleukin-17/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model.

Authors:  Malena M Pérez; Larissa M S Martins; Murilo S Dias; Camila A Pereira; Jefferson A Leite; Enrico C S Gonçalves; Paula Z de Almeida; Emanuelle N de Freitas; Rita C Tostes; Simone G Ramos; Marcel R de Zoete; Bernhard Ryffel; João S Silva; Daniela Carlos
Journal:  Immunology       Date:  2018-12-27       Impact factor: 7.397

Review 2.  Microbiota and metabolic diseases.

Authors:  Alessia Pascale; Nicoletta Marchesi; Cristina Marelli; Adriana Coppola; Livio Luzi; Stefano Govoni; Andrea Giustina; Carmine Gazzaruso
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

3.  Prebiotic Effect of Fructooligosaccharides from Morinda officinalis on Alzheimer's Disease in Rodent Models by Targeting the Microbiota-Gut-Brain Axis.

Authors:  Diling Chen; Xin Yang; Jian Yang; Guoxiao Lai; Tianqiao Yong; Xiaocui Tang; Ou Shuai; Gailian Zhou; Yizhen Xie; Qingping Wu
Journal:  Front Aging Neurosci       Date:  2017-12-08       Impact factor: 5.750

Review 4.  Protective effect of hydroxychloroquine on rheumatoid arthritis-associated atherosclerosis.

Authors:  Na Shi; Shuangyue Zhang; Gregg Silverman; Mengtao Li; Jun Cai; Haitao Niu
Journal:  Animal Model Exp Med       Date:  2019-04-19

Review 5.  Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases.

Authors:  Md Rayhan Mahmud; Sharmin Akter; Sanjida Khanam Tamanna; Lincon Mazumder; Israt Zahan Esti; Sanchita Banerjee; Sumona Akter; Md Rakibul Hasan; Mrityunjoy Acharjee; Md Sajjad Hossain; Anna Maria Pirttilä
Journal:  Gut Microbes       Date:  2022 Jan-Dec

6.  Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma.

Authors:  Jun Gong; Shant Thomassian; Sungjin Kim; Gillian Gresham; Natalie Moshayedi; Jason Y Ye; Julianne C Yang; Jonathan P Jacobs; Simon Lo; Nick Nissen; Srinivas Gaddam; Mourad Tighiouart; Arsen Osipov; Andrew Hendifar
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

7.  NOD2 Deficiency Promotes Intestinal CD4+ T Lymphocyte Imbalance, Metainflammation, and Aggravates Type 2 Diabetes in Murine Model.

Authors:  Daniela Carlos; Malena M Pérez; Jefferson A Leite; Fernanda A Rocha; Larissa M S Martins; Camila A Pereira; Thais F C Fraga-Silva; Taís A Pucci; Simone G Ramos; Niels O S Câmara; Vânia L D Bonato; Rita C Tostes; João S Silva
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

8.  Akkermansia muciniphila Enhances the Antitumor Effect of Cisplatin in Lewis Lung Cancer Mice.

Authors:  Zhuo Chen; Xiang Qian; Shasha Chen; Xiaoxuan Fu; Guanjun Ma; Aiqin Zhang
Journal:  J Immunol Res       Date:  2020-08-07       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.